Artelo Biosciences Stock Soars After Withdrawing SEC Filing

Artelo Biosciences, Inc. (NASDAQ:ARTL) shares are trading higher Friday after the company announced the withdrawal of its SEC Registration Statement as it doesn’t intend to sell securities at this time. Artelo Biosciences stock is surging to new heights today. Why is ARTL stock surging? Registration Statement Withdrawn, Offering Plans Paused Artelo Biosciences requested the withdrawal of its Registration Statement on Form S-1, initially filed with the U.S. Securities and Exchange Commission on March 20 and declared effective on March 25. The company said it does not intend to pursue the contemplated securities offering at this time and confirmed that no securities were issued or sold under the filing. Artelo also noted that fees paid to the SEC in connection with the filing will be credited for future use. Rebound Gains Strength, But Broader Trend Still Damaged Artelo is trading 69.7% above its 20-day SMA and 60.7% above its 100-day SMA, showing a powerful short-term reversal even as the longer trend remains damaged. Shares are down 81.64% over the past 12 months and, at $8.37, they're still positioned much closer to the 52-week low ($2.96) than the 52-week high ($85.80). The RSI is at 39.99, which sits in neutral territory but still reflects muted momentum after prior volatility. Meanwhile, MACD is at 0.3768 and below its signal line at 0.4146, keeping a bearish tilt in place despite the price spike. The combination of RSI below 50 and bearish MACD suggests mixed momentum. Key Resistance: $8.50 Key Support: $8.00 Artelo Shares Skyrocket ARTL Price Action: At the time of publication, Artelo shares are trading 169.59% higher at $8.60, according to data from Benzinga Pro. This illustration was generated using artificial intelligence via Midjourney.